Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
2012 | Brivanib (BRI) versus Sorafenib (SOR) as First-line Therapy in Patients with Unresectable, Advanced Hepatocellular Carcinoma (HCC): Results from the Phase 3 BRISK-FL Study | Johnson, Phillip; Qin, Shukui; Park, Joong-Won; Poon, Ronnie T.; Raoul, Jean-Luc; Philip, Philip A.; Hsu, Chih-Hung; Hu, Tsung-Hui; Heo, Jeong; Xu, Jianming; Lu, Ligong; Chao, Yee; Boucher, Eveline; Han, Kwang-Hyub; Paik, Seung Woon; Robles-Avina, Jorge; Kudo, Masatoshi; Liu, David; Ezzeddine, Rana; Walters, Ian; Cheng, Ann-Lii | Hepatology | | |  |
2014 | High serum transforming growth factor beta 1 levels associated with poor survivals in patients with advanced hepatocellular carcinoma | Lin, Tzu-Hsuan; Shao, Yu-Yun; Chan, Soa-Yu; Huang, Chung-Yi; Cheng, Ann-Lii; Hsu, Chih-Hung; 鄭安理 | Cancer Res. | 0 | 0 | |
2013 | Hospital volume of percutaneous radiofrequency ablation is closely associated with treatment outcomes for patients with hepatocellular carcinoma | Lu, Li-Chun; Shao, Yu-Yun; Kuo, Raymond N. C.; Lin, Zhong-Zhe; Yeh, Yi-Chun; Shau, Wen-Yi; Hsu, Chih-Hung; Cheng, Ann-Lii; Lai, Mei-Shu | Cancer | | |  |
2014 | Increased sensitivity to Wnt/beta-catenin inhibitors in hepatocellular carcinoma cells harboring activating mutation of beta-catenin | Lin, Hsiao-Hui; Feng, Wen-Chi; Lu, Li-Chun; Hsu, Ta-Wen; Cheng, Ann-Lii; Hsu, Chih-Hung; 鄭安理 | Cancer Res. | 0 | 0 | |
2013 | Nuclear Expression of Glioma-Associated Oncogene Homo log 1 and Nuclear Factor-kappa B Is Associated with a Poor Prognosis of Pancreatic Cancer | Yang, Shih-Hung; Hsu, Chih-Hung; Lee, Jen-Chieh; Tien, Yu-Wen; Kuo, Sung-Hsin; Cheng, Ann-Lii | Oncology | | |  |
2018 | Organ-specific differential responses to immune checkpoint inhibitors in patients with advanced hepatocellular carcinoma | Lu, Li-Chun; Hsu, Chiun; Shao, Yu-Yun; Chao, Yee; Yen, Chia-Jui; Shih, I.-Lun; Hung, Yi-Ping; Chang, Chun-Jung; Shen, Ying-Chun; Guo, Jhe-Cyuan; Liu, Tsung-hao; Hsu, Chih-Hung; Cheng, Ann-Lii; YI-PING HUNG | Cancer Research | 0 | 1 | |
2006 | Phase I-Ii Trial of Weekly Gemcitabine Plus High-Dose 5-Fluorouracil and Leucovorin in Advanced Pancreatic Cancer | CHENG, ANN-LII; HSU, CHIUN; HSU, CHIH-HUNG; 鄭安理 | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | | | |
2009 | Phase Ii Study of Cetuximab Plus Weekly Cisplatin and 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin for the First-Line Treatment of Advanced Gastric Cancer | YEH, KUN-HUEI; HSU, CHIH-HUNG; HSU, CHIUN; LIN, CHING-HUNG; SHEN, YING-CHUN; CHIOU, TZEON-JYE; CHAO, YEE; CHENG, ANN-LII | JOURNAL OF CLINICAL ONCOLOGY | | | |
2007 | Phase II Trial of Weekly Paclitaxel, Cisplatin Plus Infusional High-Dose 5-Fluorouracil and Leucovorin (TP-HDFL) for Metastatic Urothelial Carcinoma | Lin, Chia-Chi; Hsu, Chih-Hung | Journal of Urology | | | |
2015 | Postchemoradiotherapy (CRT) pathologic stage classified by American Joint Committee on Cancer (AJCC) staging system to predict prognosis of patients with locally advanced esophageal squamous cell carcinoma (ESCC) | Guo, Jhe-Cyuan; Huang, Ta-Chen; Lin, Chia-Chi; Hsieh, Min-Shu; Chang, Chin-Hao; Lee, Jang-Ming; Cheng, Jason C.; Wang, Hsiu-Po; Yeh, Kun-Huei; Cheng, Ann-Lii; Hsu, Chih-Hung; 鄭安理 | Journal of Clinical Oncology | 0 | 0 | |
2013 | Prevalence of gene amplifications of SOX-2, c-MET, and FGFR1 in Asian patients with esophageal squamous cell carcinoma. | Huang, Ta-Chen; Chen, Wei-Wu; Hsu, Ta-Wen; Lin, Chia-Chi J.; Yeh, Kun-Huei; Cheng, Ann-Lii; Hsu, Chih-Hung; 鄭安理 | J. Clin. Oncol. | | | |
2020 | Role of Eg5 in Prognosis Prediction and Treatment of Hepatocellular Carcinoma | Shao, Yu-Yun; Sun, Nai-Yun; Jeng, Yung-Ming; YAO-MING WU ; Hsu, Chiun; Hsu, Chih-Hung | ResearchSquare | | 0 | |
2016 | Serum biomarkers of VEGF-A and TGF-beta 1 predict pathological response and survival of esophageal cancer patients treated with neoadjuvant chemoradiotherapy and esophagectomy | Cheng, Jason Chia-Hsien; Chiang, Yun; Hsu, Feng-Ming; Tsai, Chiao-Ling; Hsu, Chih-Hung; Lee, Jang-Ming; 成佳憲 | Cancer Immunol. Res. | 0 | 0 | |
2003 | Steroid-Tree Chemotherapy Decreases Hepatitis B Virus (Hbv) Reactivation in Hbv-Carrier Lymphoma Patients | CHENG, ANN-LII; HSIUNG, CHAO A.; SU, IH-JEN; CHEN, PEI-JER; CHANG, MING-CHIH; TSAO, CHAO-JUNG; KAO, WOEI-YAU; UEN, WU-CHING; HSU, CHIH-HUNG; TIEN, HWEI-FANG; CHAO, TSU -YI; CHEN, LI-TZONG; WHANG-PENG, JACQUELINE; 鄭安理; 陳培哲 | HEPATOLOGY | | | |
2016 | The recurrence patterns and post-recurrence survivals in patients with locally advanced esophageal squamous cell carcinoma (ESCC) treated with preoperative paclitaxel/cisplatin-based chemoradiotherapy. | Kuo, Hung-Yang; Guo, Jhe-Cyuan; Huang, Ta-Chen; Lin, Chia-Chi; Hsieh, Min-Shu; Lee, Jang-Ming; Cheng, Jason C.; Wang, Hsiu-Po; Yeh, Kun-Huei; Hsu, Chih-Hung; 成佳憲 | Journal of Clinical Oncology | 0 | 0 | |
2015 | Therapeutic effect of sorafenib is attenuated by tumor-infiltrating Ly6G+myeloid-derived suppressor cells (MDSCs) and is restored by anti-interleukin-6 (IL-6) antibody treatment in an orthotopic mouse liver cancer model | Chang, Chun-Jung; Yang, Yao-Hsu; Chiu, Chiao-Juno; Chiang, Bor-Luen; Lee, Xiao-yi; Hsu, Chih-Hung; Cheng, Ann-Lii; 鄭安理 | Cancer Res. | 0 | 0 | |
2012 | Transforming growth factor-beta mediated epithelial to mesenchymal transition contributes to in vivo resistance to sorafenib in hepatocellular carcinoma | Lin, Shiou-Der; Lin, Tzu-Hsuan; Feng, Wen-Chi; Shao, Yu-Yun; Cheng, Ann-Lii; Hsu, Chih-Hung | Cancer Res. | 0 | 0 | |
2015 | Tumor c-Met expression and prognosis of advanced hepatocellular carcinoma patients treated with sorafenib | Shao, Yu Yun; Hsiao, Chi-Huang; Lee, Ray; Puig, Oscar; Chan, Soa-Yu; Li, Yong-Shi; Hsu, Chih-Hung | Journal of Clinical Oncology | 0 | 1 | |
2013 | Unique histopathologic features of brain metastases from hepatocellular carcinoma | Shao, Yu Yun; Hsieh, Min-Shu; Huang, Chung-Yi; Lu, Li-Chun; Hsu, Chih-Hung; Cheng, Ann-Lii | Journal of Clinical Oncology | 0 | 0 | |
2013 | Vascular endothelial growth factor expression in hepatitis C virus (HCV)-related advanced hepatocellular carcinoma (HCC) compared with hepatitis B virus (HBV)-related advanced HCC | Shao, Yu Yun; Hsieh, Min-Shu; Huang, Chung-Yi; Chang, Yung-Ling; Hsu, Chih-Hung; Cheng, Ann-Lii; 鄭安理 | J. Clin. Oncol. | | | |